BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) shares passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $2.71 and traded as high as $3.11. BIO-key International shares last traded at $2.63, with a volume of 344,748 shares changing hands.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the company. Zacks Research raised BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a research report on Thursday. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, BIO-key International presently has a consensus rating of “Reduce”.
Get Our Latest Stock Analysis on BIO-key International
BIO-key International Price Performance
The business has a fifty day moving average of $2.71 and a 200-day moving average of $4.06. The stock has a market capitalization of $5.35 million, a price-to-earnings ratio of -0.64 and a beta of 0.50.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.82) by $0.26. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. The company had revenue of $1.92 million during the quarter, compared to the consensus estimate of $1.80 million. As a group, research analysts anticipate that BIO-key International Inc. will post -1.62 EPS for the current year.
BIO-key International Company Profile
BIO-key International, Inc (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices.
The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments.
BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication.
Featured Articles
- Five stocks we like better than BIO-key International
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
